The Latin America, Middle East and Africa Sleep Apnea Devices Market would witness market growth of 8.3% CAGR during the forecast period (2019-2025).
The increase in the number of people suffering from sleeping disorders is slowly leveling up, particularly the problem is very prevalent in urban and metropolitan areas, leading to a steady rise in demand for sleep apnea devices. Government authorities in the Middle East and Africa are taking initial measures to enhance healthcare facilities and with advanced sleep laboratories and sleep tests and therapies such as Hypoglossus Nerve Stimulation and expiratory positive air pressure that contribute to the growth of this sector.
New technologies are increasingly emerging on the market as a result of extensive study and technological advances that are highly convenient for treatment and therapies that drive the growth of the Middle East and Africa sleep apnea technologies sector. Increasing spending by hospitals and diagnostic centers in the Middle East and Africa is also improving the growth rate of the demand for sleep apnea devices
The growing prevalence of obstructive sleep apnea (OSA) in the global population is one of the main factors leading to market growth. Furthermore, growing awareness about the target condition, early diagnosis of disease, growing patient adherence to positive airway pressure devices, and growing medical coverage for sleep apnea devices are expected to further drive market growth over the forecast period.
Based on Product Type, the market is segmented into Therapeutic Devices and Diagnostic Devices. Based on Therapeutic Devices Type, the market is segmented into PAP Devices, Oral Devices, Nasal Devices and Chin Straps. Based on Diagnostic Devices Type, the market is segmented into Polysomnography, Respiratory Polygraphs, Pulse Oximeters and Actigraphs. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Mitsui Chemical, Inc. (Whole You, Inc.), Teleflex, Inc., ResMed, Inc., Oventus Medical Ltd., Panthera Dental, Inc. (Panthera Sleep), BRAEBON Medical Corporation, and BMC Medical Co., Ltd.
Scope of the Study
Market Segmentation:
By Product Type

  • Therapeutic Devices and
  • Diagnostic Devices


By Therapeutic Devices Type

  • PAP Devices
  • Oral Devices
  • Nasal Devices and
  • Chin Straps


By Diagnostic Devices Type

  • Polysomnography
  • Respiratory Polygraphs
  • Pulse Oximeters and
  • Actigraphs


By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Companies Profiled

  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Corporation Limited
  • SomnoMed Limited
  • Mitsui Chemical, Inc. (Whole You, Inc.)
  • Teleflex, Inc.
  • ResMed, Inc.
  • Oventus Medical Ltd.
  • Panthera Dental, Inc. (Panthera Sleep)
  • BRAEBON Medical Corporation
  • BMC Medical Co., Ltd.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free